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doi:10.1016/j.jtcvs.2008.01.036Objective: Postpneumonectomy empyema remains a clinical challenge. We proposed
an accelerated therapy without an open chest window 5 years ago. This concept was
evaluated on a larger scale in 2 centers in 2 different countries.
Methods: Between July 1995 and October 2005, 75 consecutive patients with post-
pneumonectomy empyema were treated in Szczecin, Poland (n 5 35), and Zurich,
Switzerland (n 5 40). The therapy consisted of repeated open surgical debridement
of the pleural cavity after achievement of general anesthesia, a negative pressure
wound therapy of the temporarily closed chest cavity filled with povidone-iodine–
soaked towels, and continuous suction and systemic antimicrobial therapy. If present,
bronchopleural fistulae were closed and reinforced either with a muscle flap or the
omentum. Finally, the pleural space was filled with an antibiotic solution and defini-
tively closed.
Results: Of 75 patients (63 men; median age, 59 years; age range, 19–82 years), post-
pneumonectomy empyema was present on the right in 46 patients (32 with broncho-
pleural fistula) and in 29 patients (12 with bronchopleural fistula) on the left. Median
time between pneumonectomy and postpneumonectomy empyema was 131 days
(range, 7–7200 days). Bronchopleural fistulae have been closed and additionally re-
inforced by means of different methods (omentum, 18; muscle, 11; pericardial fat,
5; azygos vein, 1). The chest was definitively closed within 8 days in 94.6% of pa-
tients. The median hospitalization time was 18 days (range, 9–134 days). Postpneu-
monectomy empyema was successfully treated in 97.3% of patients, including 10
(13%) patients who needed a second treatment cycle. Three (4%) patients died within
90 days. The median follow-up time was 29.5 moths (range, 3–107 months).
Conclusions: Treatment of postpneumonectomy empyema with the accelerated treat-
ment is effective and safe. Our results are superior compared with those in reported
series using a (temporary) chest fenestration. Patients appreciate the physical integrity
of the chest.
T
reatment of postpneumonectomy empyema (PPE) remains a serious problem,
with a reported mortality of up to 10% to 20% and a failure rate with persis-
tently open window thoracostomy of 20% or more, even in recent reports.1-4
Recommended procedures include a wide spectrum from single-stage lavage per-
formed by means of video-assisted thoracoscopy for early empyemas to repeated
cleaning of the cavity through a temporary or persistently open window thoracostomy
and various modifications for different empyema stages. Furthermore, transpositionThe Journal of Thoracic and Cardiovascular Surgery c Volume 136, Number 1 179
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of muscles into the chest or thoracoplastic procedures to
obliterate the thoracic cavity are applied.
The problem of PPE is presented by the large size of the
infected noncollapsible chest cavity, which is filled with
pus and covered by poorly vascularized infected tissue. The
surgical principles of treatment for infected spaces have
been well known since the early time of medicine and in-
cludes evacuation of pus and debridement of the infected tis-
sue combined with obliteration, marsupialization, or opening
of the infected cavity. These principles were applied for ther-
apy of PPE over the last 50 years when various treatment con-
cepts were developed. For palliative situations in critically ill
and polymorbid patients, a drainage alone or drainage fol-
lowed by a permanently open chest window for irrigation
was or still is the treatment of first choice in some centers.
However, the open window thoracostomy is not well ac-
cepted by patients and interferes with their quality of life.
Consequent surgical debridement in combination with sys-
temic antibiotic therapy is necessary to achieve an infec-
tion-free closed chest. PPEs are often associated with
a bronchopleural fistula (BPF), which further complicates
the situation. For successful therapy, the open bronchial
stump has to be closed and reinforced with well-vascularized
tissue.5 During the last 2 decades, the concept of the open
chest window first described by Clagett and Geraci6 was
modified, especially by Pairolero and colleagues from the
Mayo clinic in Rochester, Minnesotta.1,3,4,7,8 However, the
course of treatment is usually long, and during this time, pa-
tients have to deal with an open chest window in their body.
Furthermore, the open chest window remains life-long in up
to one third of their patients.2
In 1995, we were contacted by a 25-year-old woman with
a left-sided PPE without a BPF for more than 10 years after
a pneumonectomy for unilobar bronchiectasis that was per-
formed elsewhere. The cavity was infected with Pseudomo-
nas species, and the pus drained itself over several
submammary fistulas. During the last years, she underwent
multiple treatment attempts with drains and lavage over
months but refused to undergo an open chest window or
a thoracoplastic procedure, which was recommended to
her. We applied, for the first time, an accelerated treatment
concept for chronic PPE in which we performed repeated
scheduled mechanical debridement and packing of the pleu-
ral cavity with povidone-iodine–soaked dressings and closed
the chest temporarily after each session. Surprisingly, we
were able to finally close the chest within 10 days, and de-
spite a subcutaneous abscess, which was easy to treat, she180 The Journal of Thoracic and Cardiovascular Surgery c Julyremained infection free since then. This experience encour-
aged us to apply this concept consecutively in all patients
with PPE, even in the presence of BPFs. The results of the
first experience with 20 consecutive patients were published
in 2001.7 Supported by our results and the positive experi-
ences reported to us from colleagues in other institutions
and countries who applied our concept, this approach be-
came the treatment of choice for all patients with PPE,
even those patients after an extrapleural pneumonectomy.
To prove the reproducibility and efficacy of this treatment,
we included the experience of the members of the Thoracic
Surgery Department of Pomeranian Medical University in
Szczecin, Poland, who applied the same approach in a stan-
dardized fashion to their patients after a visit to our institution
in 1998 and report them here.
Materials and Methods
From July 1995 through October 2005, 75 consecutive patients with
early (n 5 30) and late (n 5 45) PPE were operated on at Pomera-
nian Medical University in Szczecin, Poland (since 1998), and at the
division of thoracic surgery of the University Hospital of Zurich,
Switzerland. We defined late PPE as the time of occurrence of
PPE more than 90 days after pneumonectomy. Twenty-four patients
were referred to us after 1 or several unsuccessful surgical attempts
elsewhere. Thirty-five patients have been treated in Szczecin, and 40
patients have been treated in Zurich. Patients and results are de-
scribed as 1 cohort independent from the site of treatment because
the characteristics of both groups are comparable (Table 1).
Symptoms at admission included malaise, fever, and occasion-
ally cough. BPF was mostly associated with position-dependent
expectoration of serosanguinous or purulent sputum. On chest ra-
diographic analysis, a mediastinal shift to the contralateral side
might have been present, especially in early PPE. BPF was associ-
ated with lowering of the fluid level in the postpneumonectomy
space. Every patient was evaluated with a chest computed tomo-
graphic scan, as well as bronchoscopy, when a BPF was suspected
either on clinical or radiologic signs. If BPF was suspected, chest
tube thoracostomy was performed to avoid contamination of the re-
maining lung and for repositioning of the mediastinum. The diagno-
sis of empyema was based on clinical signs, radiologic features (eg,
contrast enhancement of the pleura on chest computed tomographic
scan), and the macroscopic appearance (pus), ph (,7.25), and mi-
crobiologic results from the pleural fluid. Patients with early PPE
typically had fever, malaise, thoracic pain, and dyspnea. In contrast,
patients with late PPE showed more a pattern of chronic infection
most commonly with mild malaise and anorexia and often without
fever. Broad-spectrum antimicrobial therapy (culture specific) was
administered at least 24 to 48 hours before surgical revision.
Results of bacteriology of the pleural cavity were found to be
positive in 50 (66.6%) patients for 1 or several microorganisms,
including fungi in 9 cases (Candida albicans, n 5 5; Aspergillus
species, n 5 4; Table 2).
The most common indication for pneumonectomy was non–
small lung cancer (n 5 61, 81.3%), followed by different benign
pathologies (n 5 7, 9.3%), mesothelioma (n 5 5, 6.7%), and other
malignant diseases (n5 2, 2.7%). Of the 70 patients operated on for
a malignancy, 36 (51.4%) had either neoadjuvant or adjuvant2008
Schneiter et al General Thoracic Surgery
G
TSchemotherapy (14 neoadjuvant/2 adjuvant), radiotherapy (2 neoad-
juvant/12 adjuvant), or both (1 neoadjuvant/5 adjuvant) before the
onset of PPE. All 5 patients with malignant mesothelioma were
treated with induction chemotherapy before the extrapleural pneu-
monectomy. The pericardium was reconstructed with xenopericard
(PERI-Guard, Synovis) and the diaphragm with Mersilene-Mesh
(Ethicon).
Forty-six (61.3%) patients had a right-sided PPE, 4 of them after
a right-sided pleuropneumonectomy and 29 (38.6%) after left-sided
resections (1 after a pleuropneumonectomy). Of the 7 patients with
benign disease, 4 were operated on for a destroyed lung because of
tuberculosis and 2 for major hemoptoe (1 because of severe bronchi-
ectasis), and 1 had a large hamartoma of the central airways that was
otherwise not resectable.
The operative technique7 includes repeated surgical debridement
of the chest cavity after achievement of general anesthesia every 48
hours with temporary closure of the chest, which is filled with povi-
done-iodine–soaked towels, and finally obliteration of the cavity
with an antibiotic solution.
In detail, patients are intubated with a double-lumen endotra-
cheal tube to protect the contralateral lung until a BPF is definitively
ruled out. The previous thoracotomy (generally an anterolateral in-
cision) is reopened, paying attention not to harm the soft tissue. A
radical debridement of the pleural cavity is performed by means
of parietal pleurectomy if possible and/or curettage of all necrotic
and fibrinous infected tissue from the chest wall and diaphragm
with a sharp spoon and/or sponges on the mediastinum followed
by irrigation with diluted povidone-iodine solution (1:10). The de-
bridement on the mediastinummust be carried out carefully to avoid
injury of the hilar structures, especially when curettage is used. The
presence of a small BPF is usually confirmed by flooding the chest
cavity with saline and observing escaping air bubbles from the hole
in the bronchial stump. Various techniques for closure are applied
TABLE 1. Comparison of patients' characteristics between
the 2 centers
Zurich, Switzerland Szczecin, Poland
Observation period
July 1995–October
2005
January 1998–January
2005
No. of pneumonectomies 447 708
Age, y (median/range) 59 (23–82) 60 (19–80)
Women/men 6/34 6/29
PPE in own
institution/referred
20/20 31/4
Incidence of PPE, % 4.47 4.43
Side right/left 28/12 18/17
BPF right/left 24/5 8/7
Indication for
pneumonectomy
NSCLC 29 32
Mesothelioma 4 1
Other disease 7 2
Early PPE (,90 d) 24 6
Late PPE (.90 d) 16 29
PPE, Postpneumonectomy empyema; BPF, bronchopleural fistula; NSCLC,
non–small cell lung carcinoma.The Journal of Thordepending on the size of the hole, the length of the bronchus, the
quality of the bronchial wall, and its fixation in the mediastinum.
In case of a long bronchial stump, the bronchus is shortened and
closed by means of stapling or suturing. In short stumps closure
techniques vary again based on the size of the hole and the condition
of the surrounding tissue. When applicable, the BPF is closed with
direct interrupted sutures (3-0 or 4-0 PDS sutures) and reinforced
with a muscle flap or omentum. In large bronchial holes in a short
stump or a bronchus, which can be fixed in the mediastinum, direct
closure of the BPF is not feasible. This is typically the case in late-
occurring and chronic empyemas. In these situations we close the
bronchial opening with a parachute technique, preferentially using
the omentum pedicle as a patch. The pedicle is placed on the stump
without tension to cover the opening and is fixed with interrupted
4-0 PDS sutures to achieve an airtight closure. The packing with po-
vidone-iodine–soaked towels applies the necessary counterpressure
during coughing until the omentum or muscle is adherent to the
mediastinum.
To expose the omentum, a short upper midline incision is per-
formed, and the omentum is freed from the transverse colon and
mesocolon and dissected from the stomach along the greater curva-
ture. Pediculated on the right gastroepiploic artery, it is brought into
the pleural cavity through a substernal tunnel. By placing the omen-
tum into the thorax, the pedicle of the omentum must not be twisted,
and the diameter of the tunnel should be large enough to maintain
vascular flow but small enough to avoid herniation of abdominal
organs. The omentum is then sutured with interrupted sutures on
the bronchial stump. In addition, the omentum is fixed to the medi-
astinum.
At the end of every surgical intervention (with or without BPF)
but before the definitive closure, the pleural cavity is packed with
dressings soaked with povidone-iodine solution (diluted 10:1),
carefully avoiding a mediastinal shift through overstuffing the tho-
racic cavity. A chest tube on 5 to 10 cm H2O suction is placed be-
tween the chest wall and towels to apply as a negative pressure
wound therapy and to avoid overfilling of the cavity with reactive
effusion and to protect the soft tissue from the potential contami-
nated intrathoracic fluid. The thoracotomy is temporarily closed
by adapting the ribs with 3 to 4 interrupted sutures and a running
suture of the fascia and closure of the skin with clips. The patient
is extubated and mobilized out of bed. Preferentially, he or she is
walking around on the regular ward between interventions. Every
48 hours, the antiseptic packings are changed, and the surgical de-
bridement, using curettage mainly, is repeated in the operating
TABLE 2. Preoperatively assessed microbiology (culture)
of pleural fluid
Patients with
positive bacteriology
50 (66.6%)
Gram-positive germs Staphylococcus species (SKN) 20 (14)
Streptococcus species 14
Other 9
Gram-negative germs Pseudomonas species 10
Serratia species 6
Other 11
Fungi Candida albicans 5
Aspergillus species 4acic and Cardiovascular Surgery c Volume 136, Number 1 181
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Zurich, Switzerland Szczecin, Poland Whole cohort
Success rate after first treatment n 5 36; 90% n 5 29; 82.9% n 5 65; 86.7%
Recurrence rate n 5 4; 10% n 5 6; 17.1% n 5 10; 13.3
Overall success rate (including second attempt) n 5 39; 97.5% n 5 34; 97.1% n 5 73; 97.3%
30-d Mortality n 5 1; 2.5% n 5 0 n 5 1; 1.3%
90-d Mortality n 5 1; 2.5% n 5 1; 2.8% n 5 2; 2.7%
Closed chest n 5 39*; 97.5% n 5 35y; 100%
*One patient died before treatment was completed. yOne patient remained a `` drain carrier.''theater after achievement of general anesthesia until the chest cavity
is macroscopically clean. Finally, the pleural space is obliterated
with an antibiotic solution, and the thoracotomy is definitively
closed watertight.
The composition of the antibiotic solution depends on the micro-
biologic findings. Typically, it consists of 0.3 g of netilmicin, 2.2 g
of ampicillin/clavulanic acid, and 1.0 g of vancomycin per liter of
saline. Depending on the resistance of the germ, accessory antibiotic
agents or fungicides (0.4 g of fluconazol or 1 mg/kg amphotericin)
were added to the solution.
The preoperatively started parenteral antibiotic treatment is con-
tinued.
BPF is closed during the first attempt if possible to avoid contam-
ination of the contralateral lung, especially if the hole is large. In
some situations with pinhole lesions and advanced empyemas, it
seemed to be advantageous to achieve a clean chest and mediasti-
num first, and therefore closure and reinforcement of the BPF is
done during the second intervention.
At final closure of the rib cage, the muscle layers (m. pectoralis
major and m. serratus) and the subcutaneous tissue are closed with
running sutures.
Results
Therewere 75 patients (63men and 12women)with amedian
age of 59 years (range, 19–82 years). The median time inter-
val between pneumonectomy and diagnosis of PPE was 131
days (range, 7–7200 days). In 45 (60%) of the patients, the
described treatment of PPEwasmore then 90 days after pneu-
monectomy, with a median time of 181 days and a range of
107 days to 19.7 years (7200 days) after primary intervention.
Thirty patients showed an early PPEwith amedian time inter-
val of 36 days (range, 7–89 days). In 5 patients the empyema
was already present at the time of pneumonectomy. In 49
(65.3%) patients either chest tube drainage (n 5 37, 49.3%)
was performed initially or a puncture (n 5 12, 16%) of the
pleural cavity was performed to confirm the diagnosis. The
remaining 26 patients were operated on directly. BPF was
present in 44 (58.6%) patients, 24 times in patients with late
(.90 days after pneumonectomy) and 20 times in patients
with early PPE. The fistula occurred on the right side in 32
(72.3%) patients and on the left side in 12 patients (Table 3).
In 9 of the 44 patients with BPF, a pinhole fistula in the
staple line was found, and the bronchial stump was sutured
and protected with surrounding tissue only without reinforce-182 The Journal of Thoracic and Cardiovascular Surgery c Julyment with muscle or omentum. In the remaining 35 patients,
the bronchial stump was closed with sutures and reinforced
with omentum (n5 18), muscle flap (n5 11), and pericardial
fat (n5 6). In 5 patients a direct closure of the bronchial fis-
tula was not possible because of the large size of the hole and
the scarring of the surrounding mediastinal tissue. The omen-
tum was sutured directly on the bronchial wall to close the
hole. In Zurich the omentum was used as the first choice to
reinforce the bronchial stump. No complications from the
abdomen, especially no peritonitis or wound infections,
were observed. In Szczecin muscle flaps were favored with
comparable results.
The median number of interventions until final closure of
the chest, including the first rethoracotomy, was 3 (range, 1–8).
In 2 early PPEswithout fibrinopurulent secretion, the chest was
rinsed with diluted povidone-iodine and definitively closed af-
ter filling the cavity with an antibiotic solution in one interven-
tion. On the other extreme, 8 attempts were needed to achieve
a macroscopically clean pleural cavity, as well as a sufficiently
adherent omentum, to cover the bronchus and themediastinum
in 2 patients with a large bronchial stump insufficiency. In both
cases, not only bacteria but also fungi in the necrotic tissue (As-
pergillus fumigatus and Candida albicans) were cultured.
Therefore debridement was repeated until no fungal growth
was found in the chest. However, in the majority of cases, 3 in-
terventions were required to obtain a macroscopically clean
chest with healthy tissue and some granulation tissue, which
allowed definitive closing of the chest. In 94.6% (71/75) of pa-
tients, no more than 4 interventions were needed, and the chest
was definitively closed within 8 days.
The median hospitalization time was 18 days (range,
9–134 days), and the median time interval between final chest
closure and discharge was 13 days (range, 3–83 days). The
relatively long hospitalization time after definitive closure
of the chest has 2 reasons. First, patients receive intravenous
antibiotics for at least 1 week after closure of the chest, and
intravenous medication is administered in hospitals or reha-
bilitation centers only. Second, patients in Europe often
intend to stay in the hospital until full mobilization is
achieved and they are able to go home directly.
The follow-up time ranged from 3 months to 8 years, with
a median time of 29.5 months. At follow-up, 42 patients were
alive, 30 died, and 3 were lost to follow-up. Of the deceased2008
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mor progression. Of the other 13 patients, 6 died of cardiac
failure and 2 died of pulmonary embolism, and in 5 patients
the reason for death was unclear. Three (4%) patients died
during the hospitalization. One patient died 117 days after
PPE treatment of the resected native lung because of graft
failure after unilateral lung transplantation performed previ-
ously. One patient died of massive gastrointestinal bleeding
on postoperative day 23, and 1 died of unrecognized repeat
pulmonary embolism on postoperative day 82.
In 10 (13.9%) patients the empyema relapsed, in 6 of them
because of detection of an overseen BPF or a reoccurrence
between postoperative days 3 and 315. In 1 patient the fluid
level in the pleural cavity decreased on day 3 after closure of
the chest because a tiny BPF was missed during the initial
treatment despite bronchoscopic examination and intraoper-
ative underwater testing. In 1 patient the cause of recurrence
was a gastroesophageal fistula (postoperative day 47), and in
the remaining patient the reason was unknown. In 4 patients
the described procedure was repeated with success. In an-
other 4 patients a thoracomyoplasty was performed in Szcze-
cin. All recovered well, with no signs of recurrence. Two
patients refused further hospitalization for surgical revision;
one is a ‘‘drain carrier’’ at the moment.
Two patients had subcutaneous wound infections that
healed spontaneously.
Discussion
PPE is a rare complication, with an incidence of 4% to 5% in
this report, but it has occurred even more frequently in other
series.8-11 The mortality and especially the morbidity are re-
ported to be high.1-4 Various treatments have been proposed,
and their practicality depends on the stage of the empyema,
the presence of a bronchial stump insufficiency, and the over-
all condition of the patient. We report on 75 patients with
early and late PPE that are treated according to the rules of
surgical treatment of an infected space, which includes de-
bridement and cleaning of the infected area and final obliter-
ation of the cavity by filling in an antibiotic solution.
The consequent application repeated debridement after
achievement of general anesthesia in the operating theater,
together with an appropriate antibiotic therapy, leads to
a very high success rate of 97% and a low mortality rate of
4%. The insertion of povidone-iodine–soaked dressings in
the chest with a drainage and negative pressure of 5 to 10
cm H2O might additionally support the treatment by acting
as a negative pressure wound therapy concept.12,13 The pa-
tients appreciate having their chests closed generally within
a week and being without a drain or a temporary or final chest
wall window.
The accelerated treatment is well tolerated, despite several
interventions within a short period of time, probably because
the repeated procedures are short in length and the patients are
mobilized between these interventions. The majority of the de-The Journal of Thoscribed patients had a late and established empyema, or the em-
pyema was complicated with a bronchial stump insufficiency.
Several of them had unsuccessful surgical treatments else-
where. Taking these aspects into account, the reported treat-
ment seems to be particularly effective and justified.
After having started this concept more than 10 years ago in
Zurich, Switzerland, it was applied with comparable success
in Szczecin, Poland. Furthermore, many surgeons from dif-
ferent countries reported to us their successful experiences.
The concept might be considered an advancement of the pro-
cedure originally described by Clagett and Geraci5 and later
modified by Pairolero and associates. The modified concept
used at the Mayo Clinic in Rochester, Minnesota, consists
of a temporary thoracostomy (Clagett window) and repeated
changing of dressings in the patient’s room or as an outpa-
tient. Zaheer and associates1 recently reported in a series of
84 patients that the initial closure of the chest before hospital
discharge failed in 19%, and after a second Clagett proce-
dure, 88% of all patients had their chest walls successfully
closed. Eight (9.5%) patients had to live with a permanent
thoracic wall defect. BPF healing was achieved in all 55 pa-
tients. However, the recurrence rate after the first attempt was
18%, and that after the second attempt was 5%. Perioperative
mortality in their series was 7.1%.
In our series with comparable patients’ characteristics and
a similar incidence of BPF, the mortality was lower, and all
our patients had a closed chest at hospital discharge. Of the
10 (13.3%) patients with a recurrence of PPE, 6 had either
chemotherapy, radiotherapy (44–56 Gy), or both previously.
In Zurich we reapplied in these recurrences the accelerated
treatment concept, again with success. In Szczecin a thoraco-
myoplasty, as described by Jadczuk,14 was performed. All
these patients recovered with no signs of recurrence.
The accelerated concept was applied in the majority of
cases of early PPE as well. This might occasionally be an
overtreatment. However, in 2 of our cases, the chest was suc-
cessfully closed directly after debridement, indicating that in
selected cases repeated reinterventions are not necessary. It
has been shown by different authors15-17 that cleaning of
the infected chest is possible as a 1-stage procedure done
minimally invasively with the use of a video thoracoscope.
However, in patients with chronic empyema or compli-
cated with a BPF, we and others assume that only an open ap-
proach with repeated interventions will lead to a clean chest
cavity.1,10,18,19
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Discussion
Dr Francis C. Nichols (Rochester, Minn). In 1915, an eventual
president of this association and the Mayo Clinic’s first thoracic sur-
geon, Samuel Robinson, wrote, and I quote, ‘‘Certain thoracic dis-
eases, which for generations have fallen to the lot of the surgeons,
are yet badly handled. Conspicuous among these is the patriarch
of the surgical scrap-heap, chronic empyema.’’ Dr Robinson then
went on to say that there is obvious opportunity for improvement
in the treatment of this disease, and I think that remains true today.
Prevention remains the most effective method of dealing with PPE
and BPF, and as we all know, among these preventative measures
are avoidance of contamination of the pleural space during pneumo-
nectomy and not leaving the bronchial stump too long while at the
same point in time not devascularizing the stump and the prophylac-
tic reinforcement of the stump in the face of what I call hostile
conditions, namely radiation and certain infections. Despite these
precautions, these problems continue to occur.184 The Journal of Thoracic and Cardiovascular Surgery c JulIn our most recent series, we reviewed 84 patients with PPE over
a 16-year period of time. Our mortality was 7%, and our median hos-
pital stay was 30 days. Therefore you and your colleagues are to be
commended on the results of your management. Although every
death is a tragedy, the 4% mortality you report is noteworthy;
with median follow-up of almost 21ˇ/2 years, your ultimately success-
ful treatment of 97% of the patients is also commendable, and be-
cause your median hospital stay is 18 days, that is enviable.
As we all know and have heard, improvements in the manage-
ment of this disease have occurred, including the Clagett procedure
and its modification, whereby living tissue is transposed into the tho-
racic space. We believe that muscles of the chest wall are ideal for
transposing into the chest because all are large enough and long
enough to reach most intrathoracic locations. Most frequently we
choose the serratus anterior, the latissimus dorsi when it is still avail-
able, and the pectoralis major muscles. Given our success with these
muscles, we have rarely used omentum because we would like to
avoid opening the contaminated abdominal cavity.
I have a few questions. I would like to focus first on the BPFs.
Forty-four of your patients (ie, 58%) had a BPF. You stated that if
a BPF was present, you protected the contralateral lung. We believe
the protection of the contralateral lung is actually paramount in all
cases and use a single-lumen endotracheal tube to block off the re-
maining main stem bronchus or a double-lumen tube. Some of the
fistulae you saw were small and might have only been detected in
the operating room. Of the 44 BPFs, how many were only identified
in the operating room?
Dr Schneiter. Dr Nichols, thank you for your questions, and
thank you for your comments.
As you expected, we use mostly a double-lumen endotracheal
tube and rarely a single-lumen tube, which is positioned into the re-
maining main bronchus during anesthesia to protect the stump but
especially the contralateral lung. All BPFs were suspected in the
clinical or radiologic presentation, but 5 of them were tiny and
only detected during the operation by applying air pressure to the
water-submerged stump.
DrNichols. This leads to my next question. Focusing on the sub-
set of BPF, 9 patients, as you put it, had pinhole insufficiency, in
which merely the pinhole was sutured and protected with surround-
ing tissue. There were 10 patients who ultimately experienced recur-
rent empyema, and 6 of those 10 had BPFs found at re-exploration.
Howmany of these 6 came from this pinhole and local tissue control
group? Additionally, what do you mean by local tissue because
these chests are usually very scarred and inflamed?
Dr Schneiter. You are absolutely right that it is impossible to
use any local tissue in late-occurring empyemas because of the
explanation you just gave. In 2 of these 6 patients with recurrence
of the BPF, both only a few days after definitive closure in the first
attempt, a pericardial fat flap was used for covering. We used peri-
cardial fat in another 3 patients without further complications.
Dr Nichols. You transposed omentum in 18 cases, a variety of
muscle flaps in 11 cases, a pericardial fat pad in 5 cases, and an azy-
gos vein actually in 1 case. Therefore of the 6 BPFs, how many of
those actually had soft tissue coverage in the first place? I think
you might have just answered part of the question, but what failed?
Dr Schneiter. There was failure in 2 in which the pericardial fat
flap was applied. The other 3 with the same type of coverage healed
fine. Therefore we believe that in very early cases of empyemay 2008
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TScaused by pinhole bronchial stump insufficiencies, local soft tissue
can be applied as a first choice when a well-vascularized pericardial
fat flap can be prepared. However, in Zurich we use the omentum as
the first choice with excellent success, which is in contrast to our
colleagues in Szczecin, who prefer to apply extrathoracic muscle
coverage.
Dr Nichols. I am intrigued by your use of omentum. In your
manuscript you failed to talk about operative morbidity. Were there
any intra-abdominal complications related to the use of the omen-
tum, peritonitis in particular?
Dr Schneiter. Surprisingly, we did not observe peritonitis or any
wound infection or any other abdominal complications in our
patients.
Dr Nichols. In the manuscript you talk about repeatedly closing
the skin. You had amedian of 3 repeat pack changes, and as opposed
to most of us who would just pack the chest open, you actually close
the skin, I am assuming with sutures or clips, and now based on your
presentation, you actually place a drain. In essence, you are sort of
doing a wound VAC-type approach. Is that right?
Dr Schneiter. That is right. We fill the chest with povidone-
soaked dressings, one drain between the dressings and the lateral
chest wall, and we adapt the ribs and close the fascia but leave the
muscle layer untouched until the final closure. The skin is closed
with staplers. The patient receives an elastic rib belt not only applied
during mobilization but also during bed rest.
Dr Nichols. Do you maintain suction on this closure?
Dr Schneiter. Yes, a constant suction of25 to210 cm of water
is applied, which might give a VAC-type effect to the cavity.
Dr Nichols. Finally, the median hospital stay of 18 days is truly
enviable. The median number of days, however, from the final
closure to hospital discharge was almost 2 weeks. Why were the
patients hospitalized so long after final wound closure?
Dr Schneiter. Actually, in most European hospitals patients are
treated in the hospital until they are well recovered without drains
and able to go back home. In the North American system, I would
expect that these patients would be treated ambulatory 2 to 5 days
after final closure. Maybe we will do this as well for cost reasons
in the future.
Dr Nichols. Again, thank you for the opportunity to discuss this
paper, and I commend you on your results.
Dr Schneiter. Thank you very much.
Dr Erino Rendina (Rome, Italy). Again, congratulations on an
excellent paper and on an innovative approach to this problem,
which all of us are obliged to face.
I have a few questions. You mentioned that several of your pa-
tients had undergone pleuropneumonectomy for mesothelioma,
and that implies that those patients must have had some kind of pros-
thesis in their chests. How did you handle this? Did you have to
remove the diaphragmatic prosthesis or the pericardial prosthesis?
Dr Schneiter. Actually, there were 5 patients who had pleural
pneumonectomy, and in all of them, we did remove the pericardial
prosthesis we put in because we saw some kind of infection area
around this, but we never took out the diaphragmatic prosthesis.
Dr Rendina. Thank you. There might be a high variability of
general conditions in these patients; in particular, sepsis might dete-
riorate the clinical conditions and put patients at risk for repeatedThe Journal of Thorsurgical procedures. Did you have patients who could not undergo
such an aggressive approach because of their compromised general
condition, fever, and sepsis? In other words, was any patient with
empyema that you observed over the study period excluded from
your cohort?
Dr Schneiter. Actually, we operated on all patients in the same
way.We did not do an alternative approach. But you are right. There
have been patients in a very ill status when they came.We were a lit-
tle bit surprised as well that after the first intervention, once you have
taken out the infected tissue, the patient is doing better very quickly.
And the second intervention is a very short one. It is just opening,
changing the dressings, doing an aggressive debridement again,
and repacking it with this dressing. It takes between 45 minutes
and maybe an hour. Actually, we never saw a problem.Wewere sur-
prised as well at the beginning that it works. Actually, we never had
a problem.
Dr Rendina. Finally, I concur with you that a very small pinhole
fistula can be closed right away at the first procedure. What about
larger fistulae in which the wall of the bronchus is fragile and would
not hold the sutures?Would you close it at the first procedure or wait
for the tissue integrity to be restored and buttress the suture in a later
procedure?
Dr Schneiter. Actually, it depended a little bit on the size of the
hole. If the hole is too big, then we can just pack it with these dress-
ings, and we have to be afraid that maybe some of the leakage spills
on the other side, and then we tried to cover it or to close it in the first
attempt. If the hole was not so big, we might have done it also in the
second attempt, but usually we did it in the first. And if the hole was
big and we could not close it, we did directly suture the omentum on
the hole. We did not close the hole. We directly put it on the hole.
Dr Rendina. Thank you. Congratulations again.
Dr Joel D. Cooper (Philadelphia, Pa). I want to congratulate the
authors on what I think is a great contribution.
I first heard about this sort of thing 20-some years ago when Mi-
chael Perlman from Moscow told me that they had done 75 cases
with almost universal success, and they did it with an ultrasonic gen-
erator. He said they would gradually fill the chest and add the gen-
erator until the water boiled as a form of debridement. His friends
joked that he was killing the spine of the bacteria, but I am not
sure that I believed him. I thought maybe something was lost in
translation. However, when I visited Zurich and saw some of these
patients and when I hear this presentation, I think it is a great contri-
bution. I think that you have established or at least confirmed the fact
that it is possible to take an infected chest and in virtually a single
stage, notwithstanding the few trips to the operating room, shorten
the whole process, when most of us, including myself, still put these
patients through a Clagett window, a cleanup procedure, and a filling
with tissue. I think this is a very important principle that you have
confirmed. I have one minor addition. On a few cases, when there
has been a small fistula, a little postage stamp of Surgicel with fibrin
glue put over the fistula and then reinforced with fibrin glue and then
omentum or muscle over it and then a packing gives a very good clo-
sure without air blowing up the flap. I have never done it the way
you have. I have always done it staged. But I think it is a great con-
tribution, and my congratulations to you on a good presentation.
Dr Schneiter. Thank you very much, Professor Cooper.acic and Cardiovascular Surgery c Volume 136, Number 1 185
